Filter
1562
Filtered Results: 1562
Text search:
parasites
Featured
Recommendations
131
New Publications
402
Language
Document type
No document type
705
Studies & Reports
341
Guidelines
203
Manuals
83
Fact sheets
71
Strategic & Response Plan
53
Training Material
33
Resource Platforms
23
Infographics
16
Videos
14
Situation Updates
9
Brochures
4
Dashboards/Maps
4
Online Courses
3
Countries / Regions
Global
103
India
77
Kenya
41
Latin America and the Carribbean
41
Africa
39
Uganda
37
Senegal
33
Ethiopia
30
Nigeria
26
Mozambique
26
Sierra Leone
25
Tanzania
25
Ghana
22
Nepal
22
Malawi
22
Burkina Faso
21
Rwanda
21
South Africa
20
Congo, Democratic Republic of
18
Indonesia
18
Myanmar / Burma
17
Zambia
16
Cameroon
15
Haiti
14
Bangladesh
14
Brazil
14
Philippines
13
Liberia
12
Benin
12
Venezuela
12
Germany
11
Colombia
11
West and Central Africa
11
South–East Asia Region
11
Zimbabwe
10
Peru
9
Madagascar
9
Cambodia
8
Middle East and North Africa
8
Western and Central Europe
8
Botswana
7
Paraguay
7
Argentina
6
Bolivia
6
Angola
6
East and Southern Africa
6
South Sudan
5
Namibia
5
Asia
5
Vietnam
5
Guinea
4
USA
4
Pakistan
3
Papua New Guinea
3
Sudan
3
Dominican Republic
3
Eswatini/ Swaziland
3
Ukraine
3
Honduras
3
Ecuador
3
El Salvador
3
Mexico
3
Albania
3
Southern Africa
3
Russia
3
Mali
2
Côte d’Ivoire / Ivory Coast
2
Somalia
2
Iraq
2
Jordan
2
Lebanon
2
Chad
2
Cuba
2
Lesotho
2
Chile
2
Eastern Europe and Central Asia
2
Eastern Europe
2
Laos
2
Iran
2
Morocco
1
Saudi Arabia
1
Niger
1
Afghanistan
1
Turkey
1
Syria
1
Thailand
1
China
1
Singapore
1
Central African Republic
1
North Macedonia
1
Burundi
1
Greece
1
Guatemala
1
Nicaragua
1
Sri Lanka
1
Italy
1
Congo-Brazzaville
1
Timor Leste/ East Timor
1
Qatar
1
Bulgaria
1
Georgia
1
North America
1
Gabon
1
Uruguay
1
France
1
Mauritius
1
Tunisia
1
Spain
1
Authors & Publishers
Publication Years
Category
Countries
622
Clinical Guidelines
198
Public Health
101
Key Resources
79
Women & Child Health
60
Pharmacy & Technologies
48
Capacity Building
39
Toolboxes
NTDs
298
AMR
123
Planetary Health
88
Rapid Response
33
COVID-19
33
HIV
30
Caregiver
28
Pharmacy
26
Global Health Education
24
Mental Health
23
Ebola
21
Refugee
21
Natural Hazards
15
TB
14
NCDs
12
Conflict
10
Zika
9
Cholera
5
Social Ethics
5
Health Financing Toolbox
5
Specific Hazards
3
Disability
2
Polio
2
Health Financing
1
The sixteenth meeting of the Strategic and Technical Advisory Group for Neglected Tropical Diseases (STAG-NTD) was held as a hybrid meeting, 27–28 September 2022.
Dr Ren Minghui, Assistant Director-General, Universal Health Coverage/Communicable and Noncommunicable Diseases, welcomed participan...
Despite the significant role of vector control in national leishmaniasis control programmes, the programmatic community perceives vector control as the weakest component of leishmaniasis control strategies in terms of resources, scientific evidence of the usefulness of interventions and capacity for...
Abstract: Chagas disease is caused by infection with the protozoan Trypanosoma cruzi, and although over 100 years have passed since the discovery of Chagas disease, it still presents an increasing problem for global public health. A plethora of information concerning the chronic phase of human Chaga...
This document compiles the recommendations made by the World Health Organization (WHO) and the Pan American Health Organization (PAHO) to help professionals in charge of vector control programs in Latin America and the Caribbean at the national, subnational, and local level update their knowledge in...
El presente documento reúne un conjunto de recomendaciones formuladas por la Organización Mundial de la Salud (OMS) y la Organización Panamericana de la Salud (OPS) para ayudar, a los profesionales encargados de los programas de control de vectores de Latinoamérica y el Caribe a nivel nacional, ...
Le présent document rassemble une série de recommandations émises par l’Organisation mondiale de la Santé (OMS) et l’Organisation panaméricaine de la Santé (OPS) pour aider les professionnels chargés des programmes de lutte antivectorielle en Amérique latine et dans les Caraïbes aux niv...
Schistosomiasis is widely recognized as a disease that is socially determined. An understanding of the social and behavioural factors linked to disease transmission and control should play a vital role in designing policies and strategies for schistosomiasis prevention and control. To this must be a...
This document focuses on the management of patients affected by gambiense HAT and
constitutes an update to the WHO therapeutic guidance issued in 2013. The main changes in recommendations concern the criteria and methods for deciding the treatment among the new set of therapeutic options and the pa...
Full Perscribing information on Fexinidazole Tablet for oral use
INDICATIONS AND USAGE
Fexinidazole Tablets are indicated for the treatment of both the first-stage (hemolymphatic) and second-stage (meningoencephalitic) human African trypanosomiasis (HAT) due to Trypanosoma brucei gambiense in pati...
The development of this target product profile (TPP) was led by the WHO Department of Control of Neglected Tropical Diseases (NTD) following standard WHO guidance for TPP development. In order to identify and prioritize diagnostic needs, a WHO NTD Diagnostics Technical Advisory Group (DTAG) was form...
Since 2000, concerted efforts by national programmes, supported by public–private partnerships, nongovernmental organizations, donors and academia under the auspices and coordination of the World Health Organization (WHO), have produced important achievements in the control of human African trypan...
Over the past twenty years, huge efforts made by a broad coalition of stakeholders curbed the last epidemic and brought the disease to the brink of elimination. In this paper, the latest figures on disease occurrence, geographical distribution and control activities are presented. Strong evidence in...
This technical report presents the epidemiology of human and animal leishmaniases in the EU and its neighbouring countries and concludes that the disease remains widespread and underreported in many countries of southern Europe, northern Africa, and the Middle East and that there is a need to improv...
An interregional meeting on leishmaniasis among neighbouring endemic
countries in the Eastern Mediterranean, African and European regions was organized by the World Health Organization (WHO) Regional Office for the Eastern
Mediterranean in Amman, Jordan, from 23 to 25 September 2018. The meeting w...
Les présentes lignes directrices ont pour objet de préparer les pays d’endémie à arrêter l’AMM à l’issue du traitement, à passer à la surveillance post-thérapeutique ainsi qu’à confirmer l’interruption de la transmission à l’issue de la phase 2 et à débuter la surveillance p...
Burden of T. solium: Neurocysticercosis is a disease induced by T. solium larvae penetrating human tissues, especially the nervous system. Neurocysticercosis burdens economies, societies and individuals because of the impact of epilepsy on wages, health costs and social stigmatization of sufferers. ...
Schistosomiasis is widely recognized as a disease that is socially determined. An
understanding of the social and behavioural factors linked to disease transmission and
control should play a vital role in designing policies and strategies for schistosomiasis
prevention and control. To this must b...
The fifth World Food Safety Day (WFSD) will be celebrated on 7 June 2023 to draw attention and inspire action to help prevent, detect and manage foodborne risks, contributing to food security, human health, economic prosperity, agricultural production, market access, tourism and sustainable developm...
L’objectif de cette note conceptuelle et du cadre dont elle donne les grandes lignes est l’élimination d’un groupe de MT et de leurs effets pénalisants sur la santé (maladies énumérées au tableau 1 ci-dessous) qui, pris globalement, génèrent une charge tangible pour les personnes touch...
The conditionality of this recommendation is largely driven by the current higher unit cost of pyrethroid-PBO ITNs compared
to pyrethroid-only LLINs and therefore the uncertainty of their cost-effectiveness. Furthermore, as PBO is less wash-resistant
than pyrethroids, its bioavailability declines ...
